Back
Takeda Pharmaceutical 10K Form
Sell
31
TAK
Takeda Pharmaceutical
Last Price:
13.94
Seasonality Move:
4.98%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TAK News And Ratings
See the #1 stock for the next 7 days that we like better than TAK
TAK Financial Statistics
Sales & Book Value
Annual Sales: | $29.55B |
---|---|
Cash Flow: | $208.52M |
Price / Cash Flow: | 14.14 |
Annual Sales: | $15.44 |
Price / Book: | 0.91 |
Profitability
EPS (TTM): | 0.30580 |
---|---|
Net Income (TTM): | $974.15M |
Gross Margin: | $19.66B |
Return on Equity: | 2.03% |
Return on Assets: | 0.97% |
Takeda Pharmaceutical Earnings Forecast
Key Takeda Pharmaceutical Financial Ratios
- The Gross Profit Margin over the past 25 years for TAK is 66.54%.
- The Selling, General & Administrative Expenses for TAK have been equal to 24.72% of Gross Profit Margin.
- The Research & Development expenses have been 17.12% of Revenue.
- The Interest Expense is 82.97% of Operating Income.
- The Net Earning history of TAK is 3.38% of Total Revenues.
- Per Share Earnings over the last 25 years have been positive in 15 years.
Takeda Pharmaceutical Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | TAK |
CUSIP: | 874060 |
Website: | takeda.com |
Debt
Debt-to-Equity Ratio: | 0.7 |
---|---|
Current Ratio: | 1.26 |
Quick Ratio: | 0.66 |
Price-to-Earnings
Trailing P/E Ratio: | 44.13 |
---|---|
Forward P/E Ratio: | 0 |
TAK Technical Analysis vs Fundamental Analysis
Sell
31
Takeda Pharmaceutical (TAK)
is a Sell
Is Takeda Pharmaceutical a Buy or a Sell?
-
Takeda Pharmaceutical stock is rated a Sell
The current Takeda Pharmaceutical [TAK] share price is $13.94. The Score for TAK is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.